Authors
Fanpeng Ran, Qihan Wang, Menglin Zhang, Yuhui Li, Li Wang, Kunqing Xue, Cheng Han, Jiaxue Wen, Zhigang Xu, Xiaoxiao Shi
Published in
Biomacromolecules. Volume 27. Issue 11. Pages 7734-7745. Nov 09, 2026.
Abstract
Breast cancer is a highly prevalent malignancy, but the conventional single chemotherapy suffers from insufficient therapeutic outcomes. To overcome this challenge, this study developed a dextran-based prodrug nanogel (DDIR) with dual pH/GSH responsiveness to the tumor microenvironment, enabling near-infrared (NIR) fluorescence-photothermal dual-modal imaging-guided chemo-photothermal synergistic therapy. Specifically, DDIR was prepared by conjugating doxorubicin to aldehyde-functionalized dextran via acid-sensitive Schiff-base linkages, crosslinking with a disulfide-containing linker, and encapsulating the NIR-II photothermal agent IR-1061 through hydrophobic interactions. In the acidic tumor microenvironment with elevated glutathione (GSH) levels, DDIR release drugs of DOX and IR-1061, and efficiently suppresses tumor proliferation, and ablates tumor lesions in tumor-bearing mice. This study provides a novel theranostic platform for the synergistic treatment of breast cancer and holds a promising potential for clinical translation.
PMID:
43002041
Bibliographic data and abstract were imported from PubMed on 09 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0